Understanding racial disparities and the importance of diversity in HIV research and beyond
By Janssen Pharmaceutical Companies of Johnson & Johnson
In this episode, we discuss the evolution of the HIV/AIDS epidemic with a focus on how the virus disproportionately impacts the Black community in the United States. Despite only making up 12% of the population, Black Americans account for 42% of new HIV diagnoses and 44% of HIV-related deaths. Bryan Baugh, Global Medical Affairs Leader of Infectious Diseases and Vaccines at Janssen, and Greg Millett, Vice President and Director of Public Policy at amfAR, explore the factors that contribute to this inequality, what can be done about it, and the importance of diversity in HIV research and beyond.